Valnemulin
Products Valnemulin is commercially available as a drug premix. It has been approved in many countries since 2002. Structure and properties Valnemulin (C31H52N2O5S, Mr = 564.8 g/mol) Effects Valnemulin (ATCvet QJ01XQ02) has antibacterial properties. The effects are based on inhibition of bacterial protein synthesis. Indications Treatment and prevention of swine dysentery.